Scribd Logo
Upload

Welcome to Scribd!

  • 15 views

    Ip in Pharmaceutical Industry: Shenbagapandiyan B I Year, ME (Engineering Design), Department of Mechanical Engineering

    Uploaded by

    Tomble Bravo
    The document discusses intellectual property in the pharmaceutical industry. It covers different types of patents used in pharma like product, process, formulation, and method of use patents. It also discusses how IP is intended to protect medical inventions but is often manipulated by companies to extend patents and block generics, increasing drug prices.

    Copyright:

    © All Rights Reserved
    Download as PDF, TXT or read online from Scribd

    Ip in Pharmaceutical Industry: Shenbagapandiyan B I Year, ME (Engineering Design), Department of Mechanical Engineering

    Uploaded by

    Tomble Bravo
    15 views8 pages
    The document discusses intellectual property in the pharmaceutical industry. It covers different types of patents used in pharma like product, process, formulation, and method of use patents. It also discusses how IP is intended to protect medical inventions but is often manipulated by companies to extend patents and block generics, increasing drug prices.

    Original Title

    7

    Copyright

    © © All Rights Reserved

    Available Formats

    PDF, TXT or read online from Scribd

    Did you find this document useful?

    Is this content inappropriate?

    The document discusses intellectual property in the pharmaceutical industry. It covers different types of patents used in pharma like product, process, formulation, and method of use patents. It also discusses how IP is intended to protect medical inventions but is often manipulated by companies to extend patents and block generics, increasing drug prices.

    Copyright:

    © All Rights Reserved
    Download as PDF, TXT or read online from Scribd
    Download as pdf or txt
    15 views8 pages

    Ip in Pharmaceutical Industry: Shenbagapandiyan B I Year, ME (Engineering Design), Department of Mechanical Engineering

    Uploaded by

    Tomble Bravo
    The document discusses intellectual property in the pharmaceutical industry. It covers different types of patents used in pharma like product, process, formulation, and method of use patents. It also discusses how IP is intended to protect medical inventions but is often manipulated by companies to extend patents and block generics, increasing drug prices.

    Copyright:

    © All Rights Reserved
    Download as PDF, TXT or read online from Scribd
    Download as pdf or txt
    You are on page 1of 8

    IP IN PHARMACEUTICAL

    INDUSTRY
    Shenbagapandiyan B
    I year, ME (Engineering Design),
    Department of Mechanical Engineering
    IP INTRODUCTION
    • IP any original creation of the human intellect such as arstistic, literary,
    technical or scientific creation.
    • IPR legal rights given to the inventor or creator to protect his IP for a
    certain period of time.

    TYPES OF IP PATENTS

    TRADEMARKS

    COPYRIGHT

    GEOGRAPHICAL
    INDICATION
    IP IN BIO-TECH & PHARMA
    • Bio-Tech & Pharma are ruling the IP world.
    • Though they both find ways to improve the living organism’s health
    and both produce medicines, pharma companies have more narrow
    focus on healthcare.
    • Bio-tech develop products using live material.
    • Pharma develops products using chemical compounds.
    TYPES OF PATENT IN
    PHARMA
    • for new chemical entity created.
    Product patent • with these rights, no manufacturer can create/devlop the
    same product.

    • for a certain process of creating the product.


    Process patent • But one may produce the same product with some other
    process.

    Formulation • pharmaceutical dosage form on the drug.


    • quantity of the key ingredients.
    patent
    Method of use • use of the drug to treat a disease.
    patent
    IP IN PHARMA - WHAT WAS
    INTENDED
    Protecting • patent is robust because a drug cannot be reverse-
    engineered as in the case of trade secrets.
    medical invention

    Drives economic • because investor is the exclusive owner of the


    product.
    growth

    Consumer • ensures a standard by guaranteeing quality which


    builids a dependable and efficient public health
    protection infrastructure.

    Incentives for • offer incentives for developing novel concepts into


    potential new medicines.
    global solution
    IP IN PHARMA - WHAT IS
    HAPPENING
    1. INCREASES THE PRICE OF THE PRODUCTS.
    – Companies repackage old science or make minor modifications to their existing
    products to keep their patents indefinitely.
    – Tahir Amin, co-director of the Initiative for Medicines, Access and Knowledge (I-
    MAK) contested the patents on Hepatitis C drug called sofosbuvir that in many
    places costs $1,000 (₹83,329) per pill.
    – Amin argues that in early 2000s, the world saw the power of generic drugs to
    exponentially expand the availability of HIV medicines. This had saved the
    millions of lives.
    – Now, with 7,00,000 people dying each year from Hepatitis C worldwide, we must
    once again prevent spurious patents from standing between patients and their
    right to healthy, productive lives.
    2. BLOCKS THE GENERIC DRUGS TO JOIN THE WORLD
    3. PREVENTS THE INNOVATION AND DEVELOPMENT OF MEDICINE
    SCALE OF PHARMA PATENT
    MANIPULATION
    • Between 2005 to 2015, Feldman’s research tells that 78% of drugs
    associated with new patents are not new drugs, but existing ones.
    • More than 70% of the 100 best selling drugs between 2005 and 2015 had
    their protection extended at lease once, with almost 50% receiving more
    than one exclusivity extension.
    • As per I-MAK’s 2018 report, among the 12 best selling drugs, it is found
    that the drugs have an average of 38 years of exclusivity - almost doubble
    the 20 year original patent protection and an average of 125 patent
    applicaitons.
    TAKE AWAYS
    • Developing drugs is expensive and patents are important and it is a
    reward for that investment.
    • But it is manipulated by extending the patent period by slight
    modifications to the existing products without further R&D.
    • Drug development must be one-and-done approach in which each drug
    invention receives one and only one period of exclusivity.

    You might also like

    pFad - Phonifier reborn

    Pfad - The Proxy pFad of © 2024 Garber Painting. All rights reserved.

    Note: This service is not intended for secure transactions such as banking, social media, email, or purchasing. Use at your own risk. We assume no liability whatsoever for broken pages.


    Alternative Proxies:

    Alternative Proxy

    pFad Proxy

    pFad v3 Proxy

    pFad v4 Proxy